The pedunculopontine nucleus and Parkinson's disease

Brain

Volumn 123, Issue 9, 2000, Pages 1767-1783

  Pahapill, Peter A ^a   Lozano, Andres M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Akinesia; Gait; Parkinson's disease; Pedunculopontine nucleus; Posture

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; ATROPINE; BICUCULLINE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CIMETIDINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; GLYCINE; HISTAMINE; KAINIC ACID; MEPYRAMINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NORADRENALIN; PICROTOXIN; SCOPOLAMINE; SEROTONIN; SPIPERONE; STRYCHNINE; SUBSTANCE P; UNINDEXED DRUG;

AKINESIA; BASAL GANGLION; BODY POSTURE; CEREBELLUM; GAIT; HUMAN; LIMBIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PONS; PRIORITY JOURNAL; REVIEW; SPINAL CORD; SUBSTANTIA NIGRA;

EID: 0033847609     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.9.1767     Document Type: Review

References (141)

1. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate
2. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate
3. The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia
4. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease
5. Reversal of rigidity and improvement in motor performance of subthalamic high-frequency stimulation in MPTP-treated monkeys
6. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
7. Control of gait initiation
8. Modulation of locomotor activity induced by injections of carbachol into the tegmental pedunculopontine nucleus and adjacent areas in the rat
9. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus
10. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry
11. Circling behavior elicited from the pedunculopontine nucleus: Evidence for the involvement of hindbrain GABAergic projections
12. Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: Neuroanatomical and electrophysiological evidence
13. The role of the pedunculopontine tegmental nucleus in relation to conditioned motor performance in the cat. II. Effects of reversible inactivation by intracerebral microinjections
14. Reflex behavior and programming in Parkinson's disease
15. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons
16. Role of sensory-evoked NMDA plateau potentials in the initiation of locomotion
17. The role of the pedunculopontine tegmental nucleus in relation to conditioned motor performance in the cat. I. Context-dependent and reinforcement-related single unit activity
18. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus pars compacta
19. Locomotor control in macaque monkeys
20. The initiation of normal walking
21. Afferent connections of the pedunculopontine and laterodorsal tegmental nuclei in the rat
22. Is parkinsonian gait caused by a regression to an immature walking pattern?
23. Glycine-immunoreactive neurones in the cat brain stem reticular formation
24. Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease
25. Galanin-containing fibers innervate substance P-containing neurons in the pedunculopontine tegmental nucleus in humans
26. Pallidal stimulation in Parkinson's disease patients with a prior unilateral pallidotomy
27. The pedunculopontine nucleus
28. The mesencephalic locomotor region. I. Activation of a medullary projection site
29. The mesencephalic locomotor region. II. Projections to reticulospinal neurons
30. Modulation of rhythmic function in the posterior midbrain
31. Modulation of rhythmic functions by the brainstem
32. Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus
33. Posterior midbrain-induced locomotion
34. Mesopontine neurons in schizophrenia
35. Arousal and locomotion: From schizophrenia to narcolepsy
36. Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons in the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human
37. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease
38. Separate non-cholinergic descending projections and cholinergic ascending projections from the nucleus tegmenti pedunculopontinus
39. An electrophysiological characterization of projections from the pedunculopontine area to entopeduncular nucleus and globus pallidus in the cat
40. Cholinergic projections to the substantia nigra from the pedunculopontine and laterodorsal tegmental nuclei
41. Intracellular analysis of excitatory subthalamic inputs to the pedunculopontine neurons
42. Inhibitory substantia nigra inputs to the pedunculopontine neurons
43. Neurobiological bases of rhythmic motor acts in vertebrates
44. Organization of the output of the ventral striatopallidal system in the rat: Ventral pallidal efferents
45. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: A study of seven cases
46. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease
47. Somatosensory input and thalamic projection of pedunculopontine tegmental neurons
48. Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat
49. The origins of cholinergic and other subcortical afferents to the thalamus in the rat
50. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat
51. Pallidofugal projections to thalamus and midbrain: A quantitative antidromic activation study in monkeys and cats
52. A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry
53. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy
54. Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum
55. Postural inflexibility in parkinsonian subjects
56. Spinal lamina I neurons projecting to the parabrachial area of the cat midbrain
57. The pedunculopontine tegmental nucleus: Where the striatum meets the reticular formation
58. Nucleus tegmenti pedunculopontinus: Efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase
59. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease
60. Paradoxical sleep and its chemical/structural substrates in the brain
61. Electrophysiological properties of pedunculopontine neurons and their postsynaptic responses following stimulation of substantia nigra reticulata
62. Pedunculopontine tegmental nucleus-induced inhibition of muscle activity in the rat
63. Histamine excites pedunculopontine neurones in guinea pig brainstem slices
64. Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA-L method
65. An analysis of parkinsonian gait
66. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey
67. Opposite motor effects of pallidal stimulation in Parkinson's disease
68. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
69. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease
70. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation
71. Posteroventral medial pallidotomy in advanced Parkinson's disease
72. Pedunculopontine nucleus in the squirrel monkey: Distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons
73. Pedunculopontine nucleus in the squirrel monkey: Projections to the basal ganglia as revealed by anterograde tract-tracing methods
74. Pedunculopontine nucleus in the squirrel monkey: Cholinergic and glutamatergic projections to the substantia nigra
75. Cholinergic vs. noncholinergic efferents from the mesopontine tegmentum to the extrapyramidal motor system nuclei
76. Electrophysiology of thalamic-projecting cholinergic brainstem neurons and their inhibition by ACH
77. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep; an in vitro electrophysiological study
78. Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus
79. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
80. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
81. Pallidotomy for Parkinson's disease
82. What do the basal ganglia tell premotor cortical areas?
83. Astasia and gait failure with damage of the pontomesencephalic locomotor region
84. Locomotion and stereotypy induced by scopolamine: Contributions of muscarinic receptors near the pedunculopontine tegmental nucleus
85. Single-unit activity in the primate nucleus tegmenti pedunculopontinus related to voluntary arm movement
86. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature
87. Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons
88. Electrical and chemical activation of the mesencephalic and subthalamic locomotor regions in freely moving rats
89. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
90. Injection of a GABA antagonist into the mesopontine reticular formation abolishes haloperidol-induced catalepsy in rats
91. Projections of precentral and premotor cortex to the red nucleus and other midbrain areas in Macaca fascicularis
92. The pathogenesis of gait hypokinesia in Parkinson's disease
93. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms
94. Walking patterns of men with parkinsonism
95. Activation of mesencephalic dopamine neurons by chemical stimulation of the nucleus tegmenti pedunculopontinus pars compacta
96. Nigral inputs to the pedunculopontine region: Intracellular analysis
97. Distribution and morphology of tegmental neurons receiving nigral inhibitory inputs in the cat: An intracellular HRP study
98. Firing activity of the basal ganglia and pedunculopontine nucleus in rats with nigrostriatal lesions
99. Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor
100. Injection of GABA-agonist into globus pallidus in a patient with Parkinson's disease
101. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients
102. 3H]strychnine
103. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease
104. The pedunculopontine nucleus - Auditory input, arousal and pathophysiology
105. Motor planning is impaired in Parkinson's disease
106. Gait initiation in Parkinson's disease
107. Pedunculopontine tegmental nucleus of the rat: Cytoarchitecture, cytochemistry, and some extrapyramidal connections of the mesopontine tegmentum
108. Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat
109. Distribution of molecular muscarinic (ml-m4) receptor subtypes and chloline acetyltransferase in the pontine reticular formation of man and non-human primates
110. Termination of pallidofugal pathways in man
111. Anatomical investigations of the pallidotegmental pathway in monkey and man
112. NMDA receptor-mediated synaptic input to nitric oxide synthase-containing neurons of the guinea pig mesopontine tegmentum in vitro
113. Pedunculopontine-evoked excitation of substantia nigra neurons in the rat
114. A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat
115. The reciprocal electrophysiological influence between the nucleus tegmenti pedunculopontinus and the substantia nigra in normal and decorticated rats
116. An EM and Golgi study on the connection between the nucleus tegmenti pedunculopontinus and the pars compacta of the substantia nigra in the rat
117. Single cholinergic mesopontine tegmental neurons project to both the pontine reticular formation and the thalamus in the rat
118. Opiates inhibit pedunculopontine neurones in guinea pig brainstem slices
119. Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus
120. Locomotor projections from the pedunculopontine nucleus to the medioventral medulla
121. Cholinergic projections from the midbrain and pons to the thalamus in the rat, identified by combined retrograde tracing and choline acetyltransferase immunohistochemistry
122. Nigropedunculopontine projection in the rat: An anterograde tracing study with Phaseolus vulgaris-leucoagglutinin (PHA-L)
123. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease
124. The pedunculopontine tegmental nucleus: A role in cognitive processes?
125. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies
126. Projections of cholinergic and non-cholinergic neurons of the brainstem core to relay and associational thalamic nuclei in the cat and macaque monkey
127. Quantitative assessments of gait and mobility in Parkinson's disease
128. NMDA receptors and ligands in the vertebrate CNS
129. Ionic mechanisms involved in the spontaneous firing of tegmental pedunculopontine nucleus neurons of the rat
130. Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling
131. Two types of cholinergic neurons in the rat tegmental pedunculopontine nucleus: Electrophysiological and morphological characterization
132. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease
133. Noradrenaline hyperpolarizes identified rat mesopontine cholinergic neurons in vitro
134. Cholinergic stimulation of substantia nigra: Effects on feeding, drinking, and sexual behaviour in the male rat
135. On the relationships between the striatum and the pedunculopontine tegmental nucleus
136. Cholinergic systems in the rat brain. III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain
137. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia
138. Chronic stimulation of the Kolliker-Fuse nucleus region for relief of intractable pain in humans
139. The pedunculopontine nucleus in Parkinson's disease